Copeland Capital Management reduced its stake in Eli Lilly and Company shares.
1 report, 1 independent
Updated Jul 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Copeland Capital Management reduced its stake in Eli Lilly and Company shares.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Analyst coverage is influencing stock price targets for companies including Bank of America, Eli Lilly and Company, Leerink partners, and Cantor Fitzgerald.Also in this story
- Cantor Fitzgerald increased its price target on Eli Lilly and Company stock.
- Bank of America raised its price objective and issued a buy rating on Eli Lilly and Company stock on July 25, 2026.
- Market developments on July 25, 2026, involving Eli Lilly and Company, Cantor Fitzgerald, and filings with the SEC.
The entities involved
-
Bank of America
American multinational banking and financial services corporation
-
Eli Lilly and Company
American pharmaceutical company